The COVID-19 pandemic has taken a toll on all of us, but for people living with dementia and their families, the public health crisis…
Lack of diversity in clinical trials for Alzheimer’s and other diseases is hurting research, experts say. New data offers some solutions. New research presented…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Sheri Yarbrough sat across from her parents…
Since the novel coronavirus began raging across the world last year, scientists have come to understand that patients infected with SARS-CoV-2, the virus responsible…
Two first-of-their-kind studies presented at the Alzheimer’s Association International Conference show transgender and nonbinary adults are more likely show early possible signs of dementia….
Scientists predict that access to education will reduce one’s risk of dementia, while other lifestyle factors, like smoking and diet, will contribute to the…
New research suggests that reducing harmful air pollutants can decrease dementia risk by up to 26 percent. Exposure to air pollution is widely known…
Research has shown that glucose levels, the brain’s primary source of fuel, in the central nervous system diminishes in aging, and some researchers suggest that…
In Being Patient’s LiveTalk series, Dr. David Weidman, associate medical director for research at the Banner Alzheimer’s Institute, shares insights on Eli Lilly’s investigational Alzheimer’s…
The cost of hiring a caregiver can differ from state to state and families often underestimate the costs of care which could be upwards…
In the past, scientists have overlooked the vascular system’s role in aging and dementia. But increasingly, research is showing that vascular dysfunction like damage…
Roughly one in 10 people worldwide, or over 700 million people, will experience hearing loss by 2050, and research suggests it is the leading…
Two large hospitals, Cleveland Clinic and Mount Sinai, have decided against administering Aduhelm for patients following controversy around the Alzheimer’s drug’s FDA approval drug…
This article is part of the series Diversity & Dementia, an editorially independent series produced by Being Patient with support provided by Eisai. One day, young Andres…
In the 1990s, the idea that clumps of beta-amyloid proteins are the main culprits of Alzheimer’s took off, and this line of thought —…